Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute - prolotherapyinstitute.com Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute prolotherapyinstitutecom. Uploaded by Guillermo Mata on Mar 11 2013. Suffering from chronic pain Dr Darrow can help Prolotherapy | PRP | Stem Cell Therapy in Southern California Call The Prolotherapy Institute today Call Us Today to Make an Appointment800 7342210. By: Guillermo Mata … Continue reading →

COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2013 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 19, 2013 at 9:30 a.m. ET (8:30 a.m. CT) in Chicago. A live webcast of the presentation may be accessed through the Investors page of the Companys website at http://www.Osiris.com. A replay of the webcast will be available for one week following the conference. Also, if in Chicago, please visit Osiris at booth 207 of McCormick Place for the Annual Meeting of The American Academy of Orthopaedic Surgeons, March 20-22. About Osiris Therapeutics Osiris Therapeutics, Inc., having developed the worlds first approved stem cell drug, Prochymal, is the leading stem cell company. The company is focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets. In Biosurgery, Osiris currently markets Grafix for acute and chronic wounds, and Ovation and Cartiform for orthopedic applications. Osiris is a fully integrated company with capabilities in research, development, manufacturing and … Continue reading →

Featured Article Academic Journal Main Category: Cancer / Oncology Also Included In: Stem Cell Research;Neurology / Neuroscience Article Date: 13 Mar 2013 - 3:00 PDT Current ratings for: Patient's Own Fat Cells May Help Fight Deadly Brain Cancer 5 (1 votes) 5 (2 votes) Study leader Alfredo Quinones-Hinojosa and colleagues, from the Johns Hopkins University School of Medicine in Baltimore, Maryland, write about their findings in the 12 March issue of the online open access journal PLOS ONE. The current standard treatments are chemotherapy, radiation and surgery, but even when patients receive all three they rarely live more than 18 months after diagnosis. Glioblastomas are not easy to remove. While the surgeon may remove as much of the tumor as possible, there is a risk that some stray cancer cells are left behind in areas that are difficult to reach. These particularly nimble cancer cells migrate across the entire brain and form new tumors. This ability to migrate rapidly to other parts of the brain is thought to be the main reason for the low rate of cure in this type of cancer. In a 2012 issue of PloS Biology, researchers report finding a protein that may reveal how glioblastoma … Continue reading →

Knee replacement alternatives: cartilage repair with stem cells and insulin like growth factor http://www.stemcellsarthritistreatment.com When it comes to alternatives to knee replacement surgery, regenerative medicine techniques aimed at repairing car... By: Nathan Wei … Continue reading →

Washington, March 13 (IANS) A new study has found that stem cells from the patient's own body fat could help seek out and destroy cancer cells in a type of brain tumour. Johns Hopkins researchers say they have found the stem cells from body fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumour. According to investigators, the mesenchymal stem cells (MSCs) have an unexplained ability to seek out damaged cells, such as those involved in cancer, and may provide clinicians a new tool for accessing difficult-to-reach parts of the brain where cancer cells can hide and proliferate anew. The researchers say harvesting MSCs from fat is less invasive and less expensive than getting them from bone marrow, a more commonly studied method, reports Science Daily. Results of the Johns Hopkins proof-of-principle study are described online in the journal PLOS ONE. "The biggest challenge in brain cancer is the migration of cancer cells. Even when we remove the tumour, some of the cells have already slipped away and are causing damage somewhere else," says study leader Alfredo Quinones-Hinojosa, professor of neurosurgery, … Continue reading →

NCI Cancer Center News In laboratory studies, Johns Hopkins researchers say they have found that stem cells from a patients own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumor. The investigators say so-called mesenchymal stem cells (MSCs) have an unexplained ability to seek out damaged cells, such as those involved in cancer, and may provide clinicians a new tool for accessing difficult-to-reach parts of the brain where cancer cells can hide and proliferate anew. The researchers say harvesting MSCs from fat is less invasive and less expensive than getting them from bone marrow, a more commonly studied method. Click here to read full press release. ### Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancers origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers research results are often at the forefront of studies in … Continue reading →